Kiwi study using ecstasy to treat cancer patients' depression

A ground-breaking trial which aims to use psychedelic-assisted therapy to help patients with terminal cancer has been approved. In a first for New Zealand, researchers will administer a MDMA - also known as ecstasy -assisted psychotherapy to help patients struggling with depressive thoughts and emotions.